| Literature DB >> 28605638 |
Kristen A Lemke1, Alireza Aghayee2, Randolph S Ashton3.
Abstract
Progress in deriving a spectrum of central nervous system cell phenotypes from human pluripotent stem cells has spurred significant advances in in vitro modeling and development of regenerative therapies for neurological disorders. While the clinical impact of these advances is still being evaluated, their integration with advanced tissue engineering methodologies and therapeutic approaches that induce neural circuit plasticity, respectively, remain underexplored frontiers.Entities:
Mesh:
Year: 2017 PMID: 28605638 PMCID: PMC5617772 DOI: 10.1016/j.copbio.2017.05.010
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN: 0958-1669 Impact factor: 9.740